Downloadable Slides

Share

Program Content

Activities

  • Targeting HER3 in NSCLC
    Therapeutic Relevance of HER3 in EGFR TKI-Resistant NSCLC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 03, 2023

  • HER3 Agents in NSCLC
    Current Investigational Treatments Targeting HER3 in EGFR-Positive Post-TKI NSCLC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 03, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.